Invention Grant
- Patent Title: Treatment of alpha-galactosidase a deficiency
-
Application No.: US15350785Application Date: 2016-11-14
-
Publication No.: US10245304B2Publication Date: 2019-04-02
- Inventor: Douglas A. Treco , Kenneth Loveday , Marianne Borowski
- Applicant: SHIRE HUMAN GENETIC THERAPIES, INC.
- Applicant Address: US MA Lexington
- Assignee: SHIRE HUMAN GENETIC THERAPIES, INC.
- Current Assignee: SHIRE HUMAN GENETIC THERAPIES, INC.
- Current Assignee Address: US MA Lexington
- Agency: Troutman Sanders LLP
- Main IPC: A61K8/73
- IPC: A61K8/73 ; C12Q1/54 ; A61K38/47 ; A61K38/00
Abstract:
The invention provides methods of treating α-galactosidase A deficiency. Dosage forms, methods of administration, and methods of analyzing human α-galactosidase A are also included.
Public/Granted literature
- US20170216411A1 TREATMENT OF ALPHA-GALACTOSIDASE A DEFICIENCY Public/Granted day:2017-08-03
Information query
